VivoSim Labs (VIVS) Net Shares Issued and Repurchased (2011 - 2018)
VivoSim Labs (VIVS) posted Net Shares Issued and Repurchased of $1.8 million for Q2 2018, down 35.04% on a QoQ basis from $2.7 million in Q1 2018, and down 16.94% year-over-year from $2.1 million in Q2 2017.
Analysis
VivoSim Labs (VIVS) Net Shares Issued and Repurchased (2011 - 2018) Analysis & Trends
VivoSim Labs has reported Net Shares Issued and Repurchased for 8 years, with the latest figure at $1.8 million in Q2 2018.
- On a quarterly basis, Net Shares Issued and Repurchased fell 16.94% year-over-year to $1.8 million in Q2 2018; TTM through Jun 2018 was $1.8 million, a 16.94% decrease from a year earlier, with the FY2018 full-year figure at $2.7 million, up 37.8% from the prior year.
- Net Shares Issued and Repurchased was $1.8 million for Q2 2018 at VivoSim Labs, down from $2.7 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $3.0 million in Q1 2016, with the low at $37500.0 in Q3 2015.
- Average Net Shares Issued and Repurchased over 5 years is $1.6 million, with a median of $1.8 million recorded in 2015.
- The sharpest annual moves came in 2015 and 2016: Net Shares Issued and Repurchased jumped 560.66% in 2015, then plunged 76.36% in 2016.
- Over 5 years, Net Shares Issued and Repurchased stood at $266801.0 in 2014, then sank by 85.94% to $37500.0 in 2015, then soared by 1011.04% to $416640.0 in 2016, then surged by 405.67% to $2.1 million in 2017, then decreased by 16.94% to $1.8 million in 2018.
- The last three Net Shares Issued and Repurchased figures came in at $1.8 million (Q2 2018), $2.7 million (Q1 2018), and $2.1 million (Q2 2017), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 1.75 Mn |
| Mar 31, 2018 | 2.69 Mn |
| Jun 30, 2017 | 2.11 Mn |
| Mar 31, 2017 | 1.96 Mn |
| Jun 30, 2016 | 416,640.00 |
| Mar 31, 2016 | 2.97 Mn |
| Sep 30, 2015 | 37,500.00 |
| Jun 30, 2015 | 1.76 Mn |
| Mar 31, 2015 | 1.43 Mn |
| Jun 30, 2014 | 266,801.00 |
| Mar 31, 2014 | 2.52 Mn |
| Dec 31, 2013 | 665,743.00 |
| Sep 30, 2013 | 574,540.00 |
| Jun 30, 2013 | 97,000.00 |
| Mar 31, 2013 | 927,981.00 |
| Dec 31, 2012 | 2.02 Mn |
| Sep 30, 2012 | 1.42 Mn |
| Dec 31, 2011 | 896,256.00 |